Poland – Medicinal products for the blood, blood-forming organs and the cardiovascular system – Dostawę produktów leczniczych stosowanych w programach lekowych
Opportunity Score
Confidence: 55%
Complexity: low
7 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation
AI Analysis Summary
Open tender by Śląskie Centrum Chorób Serca w Zabrzu for the supply of medicinal products used in drug programs (riociguat, bosentan, evolocumab, treprostinil, epoprostenol, selexipag, palivizumab, and three unnamed lots). 10 lots, each for a distinct pharmaceutical. Award based solely on lowest price. No estimated value provided. Submission deadline 22 June 2026 at 10:00 UTC. Electronic submission required via https://sccszabrze.ezamawiajacy.pl. Language: Polish. No framework agreement or DPS. Limited procurement documents analyzed.
Strengths
Documents available
Open procedure
Low complexity
Risks
Submission deadline in 7 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
- Submission via electronic platform at Open portal
- Tenders must be in Polish
- Variants not allowed
Buyer
Name
Śląskie Centrum Chorób Serca w Zabrzu
Location
Zabrze, POL
Website
Identifier
REGON: 001071806
Lots (10)
Supply of Riociguat as per the contract specification (SWZ).
Supply of Bosentan as per SWZ.
Supply of Evolocumabum (evolocumab) as per SWZ.
Procurement Details
Publication
21 May 2026
Deadline
22 Jun 2026, 10:00
Procedure
open
Contract
supplies
Duration
24 MONTH
Language
POL
Publication #
352545-2026
Classification
Performance: Poland
Documents (2)
Opportunity Score
Confidence: 55%
Complexity: low
7 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation